Eli Lilly's specialized model edge in pharma
Eli Lilly was framed as a top potential AI and market-cap leader through its proprietary 150-year dataset, custom GPU data centers, and specialized domain models targeting drug discovery.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.